Lexaria Bioscience Corp.
LEXXW
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
17/100
Solvency Score
50/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Mr. Richard C. Christopher
CEO
7
Employees
Kelowna
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$19MEnterprise Value
$13MPrice to Earnings
-1.82Price to Sales
36.18Price to Book
2.39Price to Cash Flow
-2.55Profitability
Return on Assets
-108.13%Return on Equity
-107.00%Return on Invested Capital
-136.91%Gross Margin
99.48%Operating Margin
-1,785.00%Net Margin
-1,784.18%Liquidity
Quick Ratio
4.24Current Ratio
4.24Cash Ratio
3.55Inventory Turnover
0.00Asset Turnover
0.06Total Liabilities
$1.9MSolvency
Debt to Assets
0.01Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
0.78Long-term Debt to Cap.
0.00Altman Z-Score
-4.44Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.